All
Lymphoma Subgroup Experiences Durable Responses from Kymriah Treatment
June 20th 2018Treatment with chimeric antigen receptor (CAR)-T cell therapy showed encouraging rates of durable responses among adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), according to updated data from the pivotal JULIET trial.
First Roundup Case Goes to Court, But the Jury Is Still Out on Whether it Causes Cancer
June 19th 2018Dewayne Johnson is the first of hundreds of patients to take Monsanto to trial, claiming that Roundup caused them to get cancer. His case will be seen even sooner than others because in California dying plaintiffs can be given expedited trials.
Genetic Predisposition Affects Treatment, Surveillance of Children with Medulloblastoma
June 18th 2018Researchers identified six gene variations that play an important role in the treatment and surveillance of children with medulloblastoma, for which they developed screening and counseling recommendations.
Testing Only the 'Tip of the Iceberg' for Common Hereditary Condition in MSI-H Tumors
June 14th 2018Lynch syndrome – a hereditary condition that increases a person’s risk for developing several types of cancer – is common among people with microsatellite instability-high (MSI-H) tumors, linking it to several new cancer types, according to large genomic study results presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
Frontline Keytruda Effective in NSCLC Subgroup, But More Work Is Needed
June 13th 2018In the Keynote-042 trial, researchers found a four- to eight-month overall survival benefit among patients with non-small cell lung cancer (NSCLC), which was correlated with higher levels of PD-L1 expression, however, further study is warranted.
FDA Approves Keytruda for Relapsed/Refractory PMBCL
June 13th 2018The FDA has granted an accelerated approval to Keytruda (pembrolizumab) for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or those who have relapsed after 2 or more prior lines of therapy.
FDA Approves Avastin Regimen for Ovarian Cancer Treatment
June 13th 2018The Food and Drug Administration approved a combination of Avastin (bevacizumab) plus the chemotherapy agents carboplatin and paclitaxel, followed by Avastin alone, for the treatment of patients with advanced ovarian cancer who have had surgical resection.
Nudes and Breast Cancer: Personal Documentary and Art
June 13th 2018Sometimes breast cancer invites us to look closely at our own bodies the way we might look at famous nudes. Creating visual art can be therapeutic, whether it involves photography or digital. Watercolors, sketches and collages could be empowering, too.
Survey Sheds Light on Why Some Use Cannabis After Stem Cell Transplant
June 13th 2018Nearly 20 percent of hematopoietic stem cell transplant (HSCT) survivors reported using cannabis, not just to ease physical and emotional side effects, but in the hopes that it would help treat their cancer, according to patient survey results presented at the 2018 of American Society of Clinical Oncology (ASCO) Annual Meeting.